P
Per Venge
Researcher at Uppsala University
Publications - 457
Citations - 34544
Per Venge is an academic researcher from Uppsala University. The author has contributed to research in topics: Eosinophil cationic protein & Eosinophil. The author has an hindex of 86, co-authored 454 publications receiving 33109 citations. Previous affiliations of Per Venge include University of Helsinki & Karolinska Institutet.
Papers
More filters
Journal ArticleDOI
Eosinophils and eosinophil cationic protein in nasal lavages in allergen-induced hyperresponsiveness: effects of topical glucocorticosteroid treatment.
TL;DR: It is suggested that the increase in responsiveness seen after an airway allergen challenge is not only a result of eosinophil activation but is a more complex phenomenon.
Journal ArticleDOI
Challenge with gliadin induces eosinophil and mast cell activation in the jejunum of patients with celiac disease.
TL;DR: Data indicate that eosinophils and mast cells are both involved in the early gliadin-induced reactions of the small intestine, and suggest that these cells are effector cells participating in the celiac lesion of the mucosa.
Journal ArticleDOI
Cationic proteins of human granulocytes. I. Isolation of the cationic proteins from the granules of leukaemic myeloid cells.
Inge Olsson,Per Venge +1 more
TL;DR: Extracts from the granule fraction obtained from leukaemic myeloid cells contained several basic proteins with electrophoretic mobilities against the cathod faster than that for lysozyme that seem to be specific for granulocytes and probably have antibacterial properties.
Journal ArticleDOI
The eosinophil and airway remodelling in asthma.
TL;DR: The objective of this review was to summarise some recent findings linking the activities of eosinophils to airways remodelling.
Journal ArticleDOI
An enzyme-linked immunosorbent assay for human carcinoembryonic antigen-related cell adhesion molecule 8, a biological marker of granulocyte activities in vivo.
TL;DR: An accurate, specific and reproducible enzyme-linked immunosorbent assay (ELISA) is described using purified native CEACam8 as standard for the measurement of CEACAM8 with a detection range of 1-64 microg/l.